Comparison of Intravenous Paracetamol and Intravenous Ketorolac in Postoperative Pain Control After Hip Surgery
DOI:
https://doi.org/10.48036/apims.v20i3.1193Abstract
Objective: To compare the analgesic effects of intravenous paracetamol versus ketorolac to control pain after hip surgery.
Methodology: This prospective comparative study was conducted at Ali Medical Centre Islamabad from Dec 2022-Dec 2023. One hundred and eighteen (n=118) patients who underwent hip surgeries were included in this study. Patients were equally distributed into two groups. In group A, intravenous Paracetamol was administered for post-surgery analgesia. In group B, intravenous ketorolac was utilized for pain relief. A Visual Analogue Scale (VAS) was used to assess pain in both groups at 2, 6-, 12-, 24-, and 48-hours post-surgery. Collected data was analyzed using the SPSS version 23.
Results: One hundred and eighteen (n=118) patients had a mean age of 61.5±0.5 years. 43(36.4%) patients were male and 75(63.6%) patients were female. Significant pain (VAS score >4) in Group A at 2, 6-, 12-, 24-, and 48-hours post-surgery was present in 29(49.1%), 9(15.2%), 9(15.2%), 7(11.8%), and 18(30.5%) patients respectively. In Group B, the significant pain (VAS score >4) was recorded at the same time intervals, in 6(10.1%), 4(6.7%), 2(3.3%), 1(1.6%), and 3(5.0%) patients respectively. The mean doses of rescue analgesia required in Group A was 1.3±0.5 and in Group B, it was 0.3±0.6 (p-value ? 0.001).
Conclusion: Intravenous ketorolac provides better analgesia than paracetamol after hip surgery. Moreover, doses of rescue analgesia required with intravenous paracetamol were more as compared to ketorolac.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Yasir Umar, Syed Junaid Ismail, Aamer Nisar, Waleed Umer, Muhammad Rizwan Ali, Shafqat Shahzad

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.








